David Happel

David Happel

Directeur Général chez SAGIMET BIOSCIENCES INC.

Fortune : 2 M $ au 31/05/2026

64 ans
Health Technology
Commercial Services
Consumer Services

Profil

David A. Happel is President, Chief Executive Officer & Director at Sagimet Biosciences, Inc. since 2022.
Former roles include Chief Executive Officer at Chrono Therapeutics, Inc. from 2018 to 2020; President & Chief Executive Officer at Cognoa, Inc. from 2020 to 2022; Director-Global Marketing at Warner-Lambert Co. in 2000; Senior Director-Pulmonary Business Unit at InterMune, Inc. in 2002; Director at Boomer Esiason Foundation; Vice President-Pulmonology at Chiron Corp.
in 2006; Head-Sales at Pfizer Inc.; Vice President-Global Sales & Marketing at Dynavax Technologies Corp.; Chief Commercial Officer & EVP at Aerovance, Inc.; Executive Vice President-Orphan Business Unit at Horizon Therapeutics Ltd. (Ireland) from 2016 to 2018; Principal at Parke, Davis & Co. LLC; and Chief Commercial Officer at Horizon Pharmaceutical LLC from 2014 to 2016.
Education includes an MBA from Indiana State University in 1991 and an undergraduate degree from Indiana University in 1984.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
28/05/2026 278 166 ( 0,45 % ) 2 M $ 31/05/2026

Postes actifs de David Happel

SociétésPosteDébut
SAGIMET BIOSCIENCES INC. Directeur Général 24/10/2022

Anciens postes connus de David Happel

SociétésPosteFin
Directeur Général 14/11/2022
Directeur Général 01/03/2020
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Corporate Officer/Principal 01/02/2018
RAPTOR PHARMACEUTICAL CORP Corporate Officer/Principal 01/10/2016
Corporate Officer/Principal 01/01/2006
Voir l'expérience en détail de David Happel

Formation de David Happel

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

82

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Services

  1. Bourse
  2. Insiders
  3. David Happel
🔇